snmjournals.org3年
Radiosynthesis of [90Y]DOTA-DUPA-Pep for clinical applications
Aiming at therapy, we continued with the new ligand DUPA-Pep based on urea-moiety ... The quality control showed no free 90YCl3 (Rt: 1.3min) and ≥98% radiochemical purity for [90Y]DOTA-DUPA-Pep (Rt: 4 ...
Pharmaceutical Technology1月
PEP-010 by PEP-Therapy for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase I drugs for Pancreatic Ductal Adenocarcinoma does not ...
Pharmaceutical Technology1月
PEP-010 by PEP-Therapy for Metastatic Ovarian Cancer: Likelihood of Approval
PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase I drugs for Metastatic Ovarian Cancer have a 77% phase ...